These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17549642)

  • 1. Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate family.
    Goldin N; Heyfets A; Reischer D; Flescher E
    J Bioenerg Biomembr; 2007 Feb; 39(1):51-7. PubMed ID: 17549642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells.
    Fingrut O; Reischer D; Rotem R; Goldin N; Altboum I; Zan-Bar I; Flescher E
    Br J Pharmacol; 2005 Nov; 146(6):800-8. PubMed ID: 16170329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria.
    Rotem R; Heyfets A; Fingrut O; Blickstein D; Shaklai M; Flescher E
    Cancer Res; 2005 Mar; 65(5):1984-93. PubMed ID: 15753398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl jasmonate: a plant stress hormone as an anti-cancer drug.
    Cohen S; Flescher E
    Phytochemistry; 2009 Sep; 70(13-14):1600-9. PubMed ID: 19660769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jasmonates in cancer therapy.
    Flescher E
    Cancer Lett; 2007 Jan; 245(1-2):1-10. PubMed ID: 16600475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jasmonates--a new family of anti-cancer agents.
    Flescher E
    Anticancer Drugs; 2005 Oct; 16(9):911-6. PubMed ID: 16162967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl jasmonate binds to and detaches mitochondria-bound hexokinase.
    Goldin N; Arzoine L; Heyfets A; Israelson A; Zaslavsky Z; Bravman T; Bronner V; Notcovich A; Shoshan-Barmatz V; Flescher E
    Oncogene; 2008 Aug; 27(34):4636-43. PubMed ID: 18408762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined chemotherapy or biotherapy with jasmonates: targeting energy metabolism for cancer treatment.
    Elia U; Flescher E
    Curr Pharm Biotechnol; 2013; 14(3):331-41. PubMed ID: 22201595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyl jasmonate induces cell cycle block and cell death in the amitochondriate parasite Trichomonas vaginalis.
    Ofer K; Gold D; Flescher E
    Int J Parasitol; 2008 Jul; 38(8-9):959-68. PubMed ID: 18294640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyljasmonate displays in vitro and in vivo activity against multiple myeloma cells.
    Klippel S; Jakubikova J; Delmore J; Ooi M; McMillin D; Kastritis E; Laubach J; Richardson PG; Anderson KC; Mitsiades CS
    Br J Haematol; 2012 Nov; 159(3):340-51. PubMed ID: 22970818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural jasmonates of different structures suppress the growth of human neuroblastoma cell line SH-SY5Y and its mechanisms.
    Tong QS; Jiang GS; Zheng LD; Tang ST; Cai JB; Liu Y; Zeng FQ; Dong JH
    Acta Pharmacol Sin; 2008 Jul; 29(7):861-9. PubMed ID: 18565287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-cancer activities of jasmonates.
    Raviv Z; Cohen S; Reischer-Pelech D
    Cancer Chemother Pharmacol; 2013 Feb; 71(2):275-85. PubMed ID: 23196641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma.
    Reischer D; Heyfets A; Shimony S; Nordenberg J; Kashman Y; Flescher E
    Br J Pharmacol; 2007 Mar; 150(6):738-49. PubMed ID: 17293888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bezielle selectively targets mitochondria of cancer cells to inhibit glycolysis and OXPHOS.
    Chen V; Staub RE; Fong S; Tagliaferri M; Cohen I; Shtivelman E
    PLoS One; 2012; 7(2):e30300. PubMed ID: 22319564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects.
    Davies NJ; Hayden RE; Simpson PJ; Birtwistle J; Mayer K; Ride JP; Bunce CM
    Cancer Res; 2009 Jun; 69(11):4769-75. PubMed ID: 19487289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional remodeling of mitochondria as an adaptive response to energy deprivation.
    Kuznetsov AV; Javadov S; Margreiter R; Grimm M; Hagenbuchner J; Ausserlechner MJ
    Biochim Biophys Acta Bioenerg; 2021 Jun; 1862(6):148393. PubMed ID: 33549532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiparasitic actions of plant jasmonates.
    Gold D; Pankova-Kholmyansky I; Fingrut O; Flescher E
    J Parasitol; 2003 Dec; 89(6):1242-4. PubMed ID: 14740919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential of Jasmonic Acid and Its Derivatives.
    Jarocka-Karpowicz I; Markowska A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cancer cell's "power plants" as promising therapeutic targets: an overview.
    Pedersen PL
    J Bioenerg Biomembr; 2007 Feb; 39(1):1-12. PubMed ID: 17404823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyl jasmonate leads to necrosis and apoptosis in hepatocellular carcinoma cells via inhibition of glycolysis and represses tumor growth in mice.
    Li J; Chen K; Wang F; Dai W; Li S; Feng J; Wu L; Liu T; Xu S; Xia Y; Lu J; Zhou Y; Xu L; Guo C
    Oncotarget; 2017 Jul; 8(28):45965-45980. PubMed ID: 28498814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.